The effect of hypnotics on next day’s diurnal symptoms in hypercapnic patients receiving long-term nocturnal noninvasive ventilation.

T. Tsuboi (Joyo, Japan), T. Oga (Kurashiki, Japan), T. Saito (Naka, Japan), S. Yano (Matsue, Japan), S. Takata (Koga, Japan), T. Ohdaira (Niigata, Japan), K. Sumi (Joyo, Japan), A. Sato (Joyo, Japan), K. Chin (Kyoto, Japan)

Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Session: Beyond continuous positive airway pressure treatment
Session type: Thematic Poster
Number: 4169
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Tsuboi (Joyo, Japan), T. Oga (Kurashiki, Japan), T. Saito (Naka, Japan), S. Yano (Matsue, Japan), S. Takata (Koga, Japan), T. Ohdaira (Niigata, Japan), K. Sumi (Joyo, Japan), A. Sato (Joyo, Japan), K. Chin (Kyoto, Japan). The effect of hypnotics on next day’s diurnal symptoms in hypercapnic patients receiving long-term nocturnal noninvasive ventilation.. 4169

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of hypnotics on sleep quality in hypercapnic patients receiving long-term nocturnal noninvasive ventilation
Source: International Congress 2014 – Home noninvasive ventilation: still a "work in progress"?
Year: 2014


The physiological effect of nocturnal non-invasive ventilation (NIV) in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 624s
Year: 2002

Impact of average volume assured pressure support (AVAPS) on sleep structure and efficacy of nocturnal bi-level ventilation in patients with chronic hypercapnic respiratory failure (CRF): a preliminary study
Source: Annual Congress 2007 - Physiological effects of noninvasive ventilation
Year: 2007



Dose-dependent effects of bronchodilator therapy on the clinical outcomes of exacerbation of COPD requiring non-invasive ventilation (NIV)
Source: Eur Respir J 2003; 22: Suppl. 45, 403s
Year: 2003

Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010

Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Hypoxic challenge flight assessments in ventilator users and patients at risk for nocturnal hypoventilation
Source: Annual Congress 2006 - Interventions and outcome in chronic respiratory failure - new aspects and deeper insights
Year: 2006


Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011

The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012

Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Duration of CPAP use in the 1st night of treatment predicts success of therapy in patients with the sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 100s
Year: 2002

Insulin resistance and patterns of continuous glucose monitoring in sleep apnoea patients: relationship with nocturnal hypoxemia and CPAP therapy
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP.
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP.
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


The influence of continuous positive airway pressure (CPAP) on response to incremental exercise in sleep apnea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 567s
Year: 2004

Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007



Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP
Source: Sleep and Breathing Conference 2021
Year: 2021